|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 105, Issue 2 563-569, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
DJ Clarke, RT Johnson and CS Downes
Department of Zoology, University of Cambridge, UK.
Yeast temperature-sensitive mutants of DNA topoisomerase II are incapable of chromosome condensation and anaphase chromatid segregation. In mammalian cells, topoisomerase II inhibitors such as etoposide (VP-16-123) have similar effects. Unfortunately, conclusions drawn from work with mammalian cells have been limited by the fact that the standard inhibitors of topoisomerase II also generate DNA strand breaks, which when produced by other agents (e.g. ionizing radiation) are known to affect progression into and through mitosis. Here we show that the anti-tumour agent ICRF-193, recently identified as a topoisomerase II inhibitor operating by a non-standard mechanism, generates neither covalent complexes between topoisomerase II and DNA, nor adjacent DNA strand breaks, in mitotic HeLa. However, the drug does prevent anaphase segregation in HeLa and PtK2 cells, with effects similar to those of etoposide. We therefore conclude that topoisomerase II function is required for anaphase chromosome segregation in mammalian cells, as it is in yeast.
This article has been cited by other articles:
|
|
 |
|
  L. A. Diaz-Martinez, J. F. Gimenez-Abian, and D. J. Clarke Chromosome cohesion - rings, knots, orcs and fellowship J. Cell Sci., July 1, 2008; 121(13): 2107 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cantero, C. Campanella, S. Mateos, and F. Cortes Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin Mutagenesis, September 1, 2006; 21(5): 321 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Andrews, A. C. Vas, B. Meier, J. F. Gimenez-Abian, L. A. Diaz-Martinez, J. Green, S. L. Erickson, K. E. VanderWaal, W.-S. Hsu, and D. J. Clarke A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. Genes & Dev., May 1, 2006; 20(9): 1162 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gong, G. L. Firestone, and L. F. Bjeldanes 3,3'-Diindolylmethane Is a Novel Topoisomerase II{alpha} Catalytic Inhibitor That Induces S-Phase Retardation and Mitotic Delay in Human Hepatoma HepG2 Cells Mol. Pharmacol., April 1, 2006; 69(4): 1320 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Watrin and V. Legagneux Contribution of hCAP-D2, a Non-SMC Subunit of Condensin I, to Chromosome and Chromosomal Protein Dynamics during Mitosis Mol. Cell. Biol., January 15, 2005; 25(2): 740 - 750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Doherty, S. R. McKeown, V. McKelvey-Martin, C. S. Downes, A. Atala, J. J. Yoo, D. A. Simpson, and W. K. Kaufmann Cell Cycle Checkpoint Function in Bladder Cancer J Natl Cancer Inst, December 17, 2003; 95(24): 1859 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Coelho, J. Queiroz-Machado, and C. E. Sunkel Condensin-dependent localisation of topoisomerase II to an axial chromosomal structure is required for sister chromatid resolution during mitosis J. Cell Sci., December 1, 2003; 116(23): 4763 - 4776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Franchitto, J. Oshima, and P. Pichierri The G2-phase Decatenation Checkpoint Is Defective in Werner Syndrome Cells Cancer Res., June 15, 2003; 63(12): 3289 - 3295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cortes and N. Pastor Induction of endoreduplication by topoisomerase II catalytic inhibitors Mutagenesis, March 1, 2003; 18(2): 105 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mauser, E. Holley-Guthrie, D. Simpson, W. Kaufmann, and S. Kenney The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces both a G2 and a Mitotic Block J. Virol., August 28, 2002; 76(19): 10030 - 10037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Grue, A. Grasser, M. Sehested, P. B. Jensen, A. Uhse, T. Straub, W. Ness, and F. Boege Essential Mitotic Functions of DNA Topoisomerase IIalpha Are Not Adopted by Topoisomerase IIbeta in Human H69 Cells J. Biol. Chem., December 11, 1998; 273(50): 33660 - 33666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Muñoz, M. Z. Zdzienicka, J.-M. Blanchard, and J. Piette Hypersensitivity of Ku-Deficient Cells toward the DNA Topoisomerase II Inhibitor ICRF-193 Suggests a Novel Role for Ku Antigen during the G2 and M Phases of the Cell Cycle Mol. Cell. Biol., October 1, 1998; 18(10): 5797 - 5808. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. J. Clarke, J. F. Gimenez-Abian, H. Tonnies, H. Neitzel, K. Sperling, C. S. Downes, and R. T. Johnson Creation of monosomic derivatives of human cultured cell lines PNAS, January 6, 1998; 95(1): 167 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Hasinoff, A. M. Creighton, H. Kozlowska, P. Thampatty, W. P. Allan, and J. C. Yalowich Mitindomide Is a Catalytic Inhibitor of DNA Topoisomerase II That Acts at the Bisdioxopiperazine Binding Site Mol. Pharmacol., November 1, 1997; 52(5): 839 - 845. [Abstract] [Full Text]
|
|
|
|
|
|
G Callaini, R Dallai, and M. Riparbelli Wolbachia-induced delay of paternal chromatin condensation does not prevent maternal chromosomes from entering anaphase in incompatible crosses of Drosophila simulans J. Cell Sci., January 1, 1997; 110(2): 271 - 280. [Abstract] [PDF]
|
|
|
|
|
|
M Morse-Gaudio and M. Risley Topoisomerase II expression and VM-26 induction of DNA breaks during spermatogenesis in Xenopus laevis J. Cell Sci., January 10, 1994; 107(10): 2887 - 2898. [Abstract] [PDF]
|
|
